It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APLM’s FA Score shows that 1 FA rating(s) are green whileRVMD’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APLM’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 6 bullish TA indicator(s).
APLM (@Biotechnology) experienced а +4.45% price change this week, while RVMD (@Biotechnology) price change was +4.95% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.
APLM is expected to report earnings on Apr 03, 2025.
RVMD is expected to report earnings on Aug 06, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
APLM | RVMD | APLM / RVMD | |
Capitalization | 6.86M | 7.17B | 0% |
EBITDA | -56.38M | -677.7M | 8% |
Gain YTD | -36.256 | -11.797 | 307% |
P/E Ratio | N/A | N/A | - |
Revenue | 0 | 0 | - |
Total Cash | N/A | 2.29B | - |
Total Debt | 4.72M | 136M | 3% |
APLM | RVMD | |
---|---|---|
RSI ODDS (%) | 1 day ago41% | 1 day ago90% |
Stochastic ODDS (%) | 1 day ago48% | 1 day ago76% |
Momentum ODDS (%) | 1 day ago53% | 1 day ago88% |
MACD ODDS (%) | 1 day ago36% | 1 day ago83% |
TrendWeek ODDS (%) | 1 day ago42% | 1 day ago81% |
TrendMonth ODDS (%) | 1 day ago90% | 1 day ago78% |
Advances ODDS (%) | 1 day ago73% | 1 day ago80% |
Declines ODDS (%) | 4 days ago90% | 10 days ago77% |
BollingerBands ODDS (%) | 1 day ago72% | 1 day ago80% |
Aroon ODDS (%) | 1 day ago90% | 1 day ago85% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBUS | 54.80 | 1.11 | +2.07% |
Invesco MSCI USA ETF | |||
DIVB | 46.03 | 0.52 | +1.14% |
iShares Core Dividend ETF | |||
PIE | 17.80 | 0.17 | +0.99% |
Invesco DW Emerging Markets Momt ETF | |||
BSMR | 23.29 | 0.12 | +0.52% |
Invesco BulletShares 2027 Muncpl Bd ETF | |||
GREI | 32.69 | N/A | N/A |
Goldman Sachs Future Real Estate and Infrastructure Equity ETF |
A.I.dvisor indicates that over the last year, APLM has been loosely correlated with HCWB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then HCWB could also see price increases.
Ticker / NAME | Correlation To APLM | 1D Price Change % | ||
---|---|---|---|---|
APLM | 100% | +0.40% | ||
HCWB - APLM | 49% Loosely correlated | +0.13% | ||
RVMD - APLM | 33% Loosely correlated | +3.04% | ||
PHAR - APLM | 31% Poorly correlated | +3.75% | ||
PYXS - APLM | 29% Poorly correlated | +0.93% | ||
KURA - APLM | 28% Poorly correlated | +0.94% | ||
More |
A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with KYMR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then KYMR could also see price increases.
Ticker / NAME | Correlation To RVMD | 1D Price Change % | ||
---|---|---|---|---|
RVMD | 100% | +3.04% | ||
KYMR - RVMD | 55% Loosely correlated | +9.32% | ||
ERAS - RVMD | 53% Loosely correlated | -1.41% | ||
CRNX - RVMD | 52% Loosely correlated | +3.15% | ||
IDYA - RVMD | 51% Loosely correlated | +1.33% | ||
DNLI - RVMD | 50% Loosely correlated | +4.17% | ||
More |